Objective To study the expression level and clinical significance of HMGB1 and RAGE in
cervical squamous epithelial carcinoma. Methods Real time quantitative polymerase chain …

To investigate the association between high mobility group box1 (HMGB1) and cervical
squamous cell carcinoma (CSCC), and explore the role of HMGB1/RAGE pathway in the …

The aim of this study was to confirm the expression of high mobility group box 1 (HMGB1)
and its receptor for advanced glycation end products (RAGE) in patients with epithelial …

Cervical cancer is the third leading cause of cancer death among women in less-developed
regions. Because of the poor survivorship of patients with advanced disease, finding new …

Objective: To investigate the expression of high mobility group protein B1 (HMGB1) and its
receptor, receptor for advanced glycation end-product (RAGE), in renal cancer tissue and …

High mobility group box 1 (HMGB1) is associated with tumor progression and a poor
prognosis; microtubule-associated protein 1 light chain 3 (LC3) plays a critical role in …

Objective To investigate the expression of the high mobility group box1 (HMGB1) in human
cervical squamous epithelial carcinoma (CSEC) and to explore the relationship of HMGB1 …

Esophageal cancer is a malignant type of cancer with a high mortality rate. The aim of this
study is to determine co-expression patterns of High-mobility group box 1 protein (HMGB1) …

Aims and background The receptor for advanced glycation end products (RAGE) is a
multiligand cell surface receptor of the immunoglobulin superfamily and a newly recognized …

High mobility group protein box1 (HMGB1) and its receptor—receptor for advanced
glycation end products (RAGE) are pivotal factors in the development and progression of …